Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05854979 · ClinicalTrials.gov registry record
Effects of GLP-1 Agonists on Gastric Volume
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 210
- Enrollment target
NCT05854979: Completed study, sponsored by Medical University of South Carolina.
NCT05854979 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 210 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05854979 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 210 participants
- Enrollment target
Study Summary
This study will enroll patients ages 18 and over who have a diagnosis of diabetes, are undergoing an elective surgery under general anesthesia and 1) are taking a GLP-1 receptor agonist medication, or 2) not taking a GLP-1 receptor agonist medication. The patients will have a gastric ultrasound prior to surgery to measure any retained gastric contents. The primary goal is to assess the effect of subcutaneous injectable GLP-1 agonists on preoperative gastric volume in fasted, diabetic surgical patients.
Primary Outcome
The gastric volume will be calculated using a validated formula.
Interventions
- DIAGNOSTIC_TEST Gastric Ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 210 participants |
| Start Date | 2023-08-09 |
| Est. Completion | 2024-04-15 |
What the finished NCT05854979 record still lists
NCT05854979 is an observational study that tracks outcomes without assigning an intervention. The registered 210 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Gastric Ultrasound is the first listed.
NCT05854979 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05854979 about?
NCT05854979 is a clinical study titled "Effects of GLP-1 Agonists on Gastric Volume". This study will enroll patients ages 18 and over who have a diagnosis of diabetes, are undergoing an elective surgery under general anesthesia and 1) are taking a GLP-1 receptor agonist medication, or 2) not taking a GLP-1 receptor agonist medication. The patients will have a gastric ultrasound prio...
What is the current status of trial NCT05854979?
This trial is currently completed. The enrollment target is 210 participants. The study started on 2023-08-09. Estimated completion is 2024-04-15.
What interventions are being tested in trial NCT05854979?
The interventions under investigation include: Gastric Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05854979?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02665923 · 210 participants
Gastric Emptying in Neonates and Infants After Formula Feeding
- NCT03322891 · 210 participants · NA
Improving Health Literacy in African-American Prostate Cancer Patients
- NCT03544489 · 210 participants · Phase 2
Effectiveness of Exercise After an ICD
- NCT04408430 · 210 participants · NA
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI